SCTX SCHEDULE 13G: SEC filing
Andreessen Horowitz-affiliated funds (AH Bio Fund II and III)
Filed with the SEC on · accession 0001725721-26-000009
SCTX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
Andreessen Horowitz-affiliated funds (AH Bio Fund II and III) filed a Schedule 13G disclosing beneficial ownership of approximately 16.3% of Scribe Therapeutics common stock, with Marc Andreessen and Benjamin Horowitz deemed beneficial owners.
Key details
✦ Ask GOAX AI about this filing — what it means for SCTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SCTX?
Click hereFrequently asked questions
What did SCTX file with the SEC on Nov 16, 2026?
SCTX filed a SCHEDULE 13G (SEC filing). Andreessen Horowitz-affiliated funds (AH Bio Fund II and III) filed a Schedule 13G disclosing beneficial ownership of approximately 16.3% of Scribe Therapeutics common stock, with Marc Andreessen and Benjamin Horowitz deemed beneficial owners.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Other SCTX SEC filings
Get alerts when SCTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days